SUMMARY Seventy-one patients presenting with acute herpes zoster ophthalmicus were followed up for six months for a prospective analysis of the natural history of the disease. Acute and chronic ocular complications, nasociliary nerve Standardised assessment forms were completed at presentation and at subsequent visits. Pain was assessed by visual analogue scale (VAS). The patient was asked to look at a 100 mm horizontal line with a zero at one end and three pluses at the other, with the instruction that the latter represented the worst pain he could possibly imagine. He was then asked to indicate with a mark along the line the severity of any pain being experienced at the time of the interview, and a measurement was taken in millimeters. At subsequent interviews a fresh line was presented. Ocular involvement, nasociliary nerve (NCN) involvement at presentation, rash severity, and duration were also assessed.
Ophthalmic involvement has been considered the most important and potentially serious of all sites for herpes zoster. It is reported as occuring in 33' to 50%2 of cases and has the highest incidence of postherpetic neuralgia (PHN).3 As a result it is the site that most often requires treatment, and this is usually prolonged.
A number of retrospective studies have looked at the natural history of herpes zoster. deMoragas and Kierland' reviewed 916 cases, of which 149 (16-3%) were trigeminal. Burgoon et al.' reviewed 206 cases, of which 36 (17.5%) were ophthalmic. Both reported a higher incidence of complications in trigeminal involvement than elsewhere. Leisegang4 and Womack and Leisegang5 have more recently reviewed respectively 94 and 86 patients with acute herpes zoster for ocular complications.
This study we believe for the first time prospectively analyses the natural history of acute herpes zoster ophthalmicus. In view of their high incidence and morbidity we have in addition looked for predictive indicators of ocular involvement and PHN in order to allow early identification and treatment of those patients most at risk.
Patients and methods
Between January and August 1984 53 patients presenting to the Accident and Emergency Department of St Paul's Eye Hospital, Liverpool, with acute herpes zoster ophthalmicus were examined. In addition a further 25 patients were examined at Manchester Royal Eye Hospital in the same period. Seven patients were excluded, four at Liverpool and three at Manchester: three patients could not understand standardised questions; two were taking homoeopathy at the time of presentation, rendering analysis of subsequent progression potentially unreliable; one died of an unrelated cause; one was admitted to another hospital and lost to follow-up. A total of 71 patients were studied.
Standardised assessment forms were completed at presentation and at subsequent visits. Pain was assessed by visual analogue scale (VAS). The patient was asked to look at a 100 mm horizontal line with a zero at one end and three pluses at the other, with the instruction that the latter represented the worst pain he could possibly imagine. He was then asked to indicate with a mark along the line the severity of any pain being experienced at the time of the interview, and a measurement was taken in millimeters. At subsequent interviews a fresh line was presented. Ocular involvement, nasociliary nerve (NCN) involvement at presentation, rash severity, and duration were also assessed.
Assessment of pain by a VAS has been shown to be reproducible for the same individual and a method that allows reliable statistical analysis.6 Like all pain assessment it is subjective, and hence direct comparisons between patients cannot be made. However, 353 S P Harding, J R Lipton, andJ C D Wells was a difference in mean time of onset of involvement between those under 60 (1.10 weeks) and those aged 60 and over (2X23 weeks), and this achieved a high level of significance (t=9-379; p<<0-001). There was no significant difference in incidence of ocular involvement in relation to age: under 40 compared with over 40 (X;=0.530; p>0-1); under 60 with over 60 (X;=0 295; p>05); under 80 with over 80 (Xy= 2-613; p>0-1). There was no significant difference in incidence of ocular involvement between the sexes (Xy=0) ( Table 3 ).
Treatment of keratitis and uveitis was initially with acyclovir ointment, and topical steroids were introduced only later in severe unresponsive cases and in several of those which went on to chronicity.
Ocular involvement when still active at six months was defined as chronic and occurred in eight of 28 initially involved patients (28X6%). Chronic eye disease occurred in 14-3% of the 56 patients studied, with an age range of 54-91. However, the difference in incidence between those under 54 and those aged 54 and over did not achieve significance (4'=2-734; p>0-05). Seven patients had keratouveitis still active at six months, two of these with an associated secondary glaucoma; a further three had neuropathic corneal ulcers. All had chronic anterior uveitis.
NASOCILIARY NERVE NCN involvement was assessed at presentation and was defined as involvement by rash of the external nasal nerve. It occurred in 21 of 56 patients (37.5%). There was a highly significant association between presence of NCN involvement at presentation and the subsequent development of ocular complications 
PAIN
Ten patients out of 56 were pain free at presentation (18%). Six of these developed pain at some time later (60%) and two of these went on to develop PHN. Four of the 56 patients (7%) were pain free throughout the course of the disease. Table 1 shows the mean VAS scores at presentation and during subsequent time bands for each of four age groups. For the 20-39 age group the mean VAS scores fell dramatically by two weeks to one month (p<001), while this fall had occurred only by six weeks to three months for the 40-59 age group (p<001). For the 60-79 age group there was a fall in mean VAS by six weeks to three months, but this was of lesser significance (p<005). For the patients aged 80 and over there was no significant fall at any time during the acute phase (p>005).
An analysis was performed by comparing pain scores at presentation with those in subsequent time bands within each group by paired t tests. Table 4 shows that compared with presentation there was a fall in incidence of pain at each subsequent time band. This achieves significance by six weeks to three months (4'=12-72; p<0-001) and is very highly significant by six months (4'=41.34; p<<O-O01). Table 5 shows that the mean pain score falls highly significantly by six weeks to three months in those patients who did not develop PHN but stayed high in those who did (paired t tests). The presence of pain at two weeks to one month was not associated with the development of PHN (xy=0-148; p>0-5) but the presence of pain at six weeks to three months was, and this highly significantly (X'=8-680; p<001).
Discussion
Frequency of infection increased with age until 70 and decreased thereafter, but with population correction there was a steady rise in incidence (Fig.  1) , conforming with previous work.'3' No cases were seen below age 20, supporting the similar findings of Burgoon et al.' and deMoragas and Kierland. However, Edgerton' found several reports of ophthalmic zoster in infancy and concluded that there are two periods in life in which infection is most likely under 14 and over 40. It is possible that some affected infants may have been referred elsewhere during our study, explaining the lack of young cases. However, it is certain that infantile ophthalmic zoster is uncommon in the healthy population. The mechanism of infection in this age group is usually exposure to varicella zoster virus in utero at the time of maternal chickenpox."' Of the 71 patients 63-4% were female, and this is consistent with previous reports.'lHowever, our age distribution analysis shows that under age 60 there is a highly significant increase in the number of males involved, while female cases were more likely among patients aged 60 and over.
Ocular complications seen in herpes zoster ophthalmicus have been well documented'." I' and occurred in 50% of our patients. Anterior uveitis was Acute pain associated with herpes zoster ophthalmicus is distinct from the later development of postherpetic neuralgia. This study shows that acute pain as measured by VAS decreases with time, and this more rapidly in younger age groups. It is common at presentation, occurring in 82-1% of patients. Of those who were pain free at presentation 60% subsequently developed pain. It is therefore apparent that the great majority experience pain at some time.
The incidence of PHN in this study was 21-4%. This is much higher than the 7% reported by Marsh" and the 9*7% reported by Burgoon et al. ' It is more in keeping with the higher incidence reported by deMoragas and Kierland.7 The development of PHN in one patient aged 25 indicates that, though less common, this is an important complication in younger patients. One patient had no pain until the onset of PHN at six months; one should not assume that the absence of acute pain implies the eventual freedom from PHN.
This study shows that patients aged 80 and over have a significantly higher chance of developing PHN than younger patients. A high VAS pain score at presentation in patients aged 60 and over was significantly associated with PHN. Analysis suggests that a high index of suspicion should be given to presentation scores in excess of 35 mm. There was a very highly significant fall in VAS scores by six weeks to three months in those who did not develop PHN, while for those who did the scores stayed high. Furthermore the presence of pain in this time band was highly significantly associated with PHN.
No association was found between PHN and ocular involvement, chronic eye disease, duration or severity of rash, sex, or nasociliary nerve involvement at presentation.
This study shows that PHN is more likely in older patients and in those who score their pain highly on VAS at presentation. These two factors therefore allow some measure of prediction of which patients should be treated. As our and other work has shown this should be early, preferably before 14 days. Furthermore the failure of VAS scores to fall as the condition progresses should alert the clinician to the impending development of PHN, one of the most severe complications of this disease. 
